ELEVATEBIO BASECAMP Trademark

Trademark Overview


On Sunday, June 9, 2019, a trademark application was filed for ELEVATEBIO BASECAMP with the United States Patent and Trademark Office. The USPTO has given the ELEVATEBIO BASECAMP trademark a serial number of 88465392. The federal status of this trademark filing is REGISTERED as of Tuesday, August 9, 2022. This trademark is owned by ElevateBio, LLC. The ELEVATEBIO BASECAMP trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of medicines; Research and development services in the field of antibodies; Research, development, engineering and testing services in the fields of immunopharmaceuticals; Biochemical research and development; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer trea...
elevatebio basecamp

General Information


Serial Number88465392
Word MarkELEVATEBIO BASECAMP
Filing DateSunday, June 9, 2019
Status700 - REGISTERED
Status DateTuesday, August 9, 2022
Registration Number6815464
Registration DateTuesday, August 9, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 8, 2019

Trademark Statements


Pseudo MarkELEVATE BIO BASE CAMP
Goods and ServicesPharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of medicines; Research and development services in the field of antibodies; Research, development, engineering and testing services in the fields of immunopharmaceuticals; Biochemical research and development; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment; Medical research services in the field of cancer; Pharmaceutical research and development; Product research and development; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical testing services and information in the field of cancer research and disease classification; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 21, 2019
Primary Code042
First Use Anywhere DateThursday, July 25, 2019
First Use In Commerce DateThursday, July 25, 2019

Trademark Owner History


Party NameElevateBio, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Party NameElevateBio, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Party NameElevateBio, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Tuesday, August 9, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 9, 2022REGISTERED-PRINCIPAL REGISTER
Friday, July 8, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, July 7, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 31, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 26, 2022USE AMENDMENT FILED
Thursday, May 26, 2022TEAS STATEMENT OF USE RECEIVED
Saturday, December 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 2, 2021SOU EXTENSION 4 GRANTED
Thursday, December 2, 2021SOU EXTENSION 4 FILED
Thursday, December 2, 2021TEAS EXTENSION RECEIVED
Friday, July 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 8, 2021SOU EXTENSION 3 GRANTED
Thursday, June 3, 2021SOU EXTENSION 3 FILED
Wednesday, July 7, 2021NOTICE OF REVIVAL - E-MAILED
Tuesday, July 6, 2021EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, July 6, 2021PETITION TO REVIVE-GRANTED
Tuesday, July 6, 2021TEAS PETITION TO REVIVE RECEIVED
Tuesday, July 6, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 5, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 10, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 10, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 10, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 13, 2021SOU EXTENSION 2 GRANTED
Thursday, December 3, 2020SOU EXTENSION 2 FILED
Tuesday, January 5, 2021NOTICE OF REVIVAL - E-MAILED
Monday, January 4, 2021EXTENSION RECEIVED WITH TEAS PETITION
Monday, January 4, 2021PETITION TO REVIVE-GRANTED
Monday, January 4, 2021TEAS PETITION TO REVIVE RECEIVED
Monday, January 4, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 4, 2021ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 21, 2020SOU EXTENSION 1 GRANTED
Wednesday, June 3, 2020SOU EXTENSION 1 FILED
Thursday, August 20, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 7, 2020NOTICE OF REVIVAL - E-MAILED
Monday, July 6, 2020EXTENSION RECEIVED WITH TEAS PETITION
Monday, July 6, 2020PETITION TO REVIVE-GRANTED
Monday, July 6, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, July 6, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 6, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2019PUBLISHED FOR OPPOSITION
Wednesday, September 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, August 31, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 29, 2019ASSIGNED TO EXAMINER
Friday, June 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, June 12, 2019NEW APPLICATION ENTERED IN TRAM